Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Virginia · 2026 Regular Session · Bill

HB 917: Compounding pharmacies; use of bulk drug substances, recordkeeping.

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 917 is a bill introduced in the Virginia House on January 13, 2026. According to its official title, it concerns: Compounding pharmacies; use of bulk drug substances, recordkeeping. Primary sponsor: Rod Willett (Democratic). It lists 1 additional sponsor. Most recent recorded action (January 27, 2026): Continued to next session in Health and Human Services (Voice Vote).

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Board of Pharmacy; compounding pharmacies; use of bulk drug substances; recordkeeping. Establishes additional requirements for when pharmacists may use bulk drug substances in compounding and specifies prohibitions on pharmacist use of (i) bulk drug substances that were withdrawn or removed from the market for reasons of safety and effectiveness or were covered by an investigational new drug application and not approved and (ii) compounded drug products that are essentially a copy of commercially available drug products. The bill permits the Board of Pharmacy to request records of all compounded drug products and requires pharmacists to furnish such records within 48 hours of such request or within a reasonable time as determined by the Board. The bill also permits the Board of Pharmacy to submit any information related to investigations, disciplinary proceedings, or inspection of a licensee to the National Association of Boards of Pharmacy.

Sponsors

Sponsors by party (alphabetical): Democratic 2

NameRolePartyChamberDistrict
Rod WillettPrimary sponsorDemocraticHouse58
Liz GuzmánCo-sponsorDemocraticHouse22

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Continued to next session in Health and Human Services (Voice Vote)
  2. Fiscal Impact Statement from Department of Planning and Budget (HB917)
  3. Referred to Committee on Health and Human Services
  4. Prefiled and ordered printed; Offered 01-14-2026 26105003D

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source